M Krutova1, M H Wilcox2, E J Kuijper3. 1. Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridium difficile (ESGCD). Electronic address: marcela.krutova@lfmotol.cuni.cz. 2. Leeds Teaching Hospitals NHS Trust & University of Leeds, Leeds, United Kingdom; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridium difficile (ESGCD). 3. Department of Medical Microbiology, Leiden University Medical Centre, Leiden, The Netherlands; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Clostridium difficile (ESGCD).
Authors: Marcela Krutova; Ales Briksi; Jan Tkadlec; Miroslav Zajac; Jana Matejkova; Otakar Nyc; Pavel Drevinek Journal: J Clin Microbiol Date: 2019-09-24 Impact factor: 5.948
Authors: Reiner Schaumann; Kevin Dallacker-Losensky; Christiane Rosenkranz; Gelimer H Genzel; Catalina S Stîngu; Wolfgang Schellenberger; Sebastian Schulz-Stübner; Arne C Rodloff; Klaus Eschrich Journal: Curr Microbiol Date: 2018-08-17 Impact factor: 2.188
Authors: Petra Bandelj; Céline Harmanus; Rok Blagus; Marko Cotman; Ed J Kuijper; Matjaz Ocepek; Modest Vengust Journal: BMC Vet Res Date: 2018-10-01 Impact factor: 2.741